Teva Pharmaceutical Industries (TEVA) Current Deferred Tax Assets (2011 - 2016)

Teva Pharmaceutical Industries (TEVA) has 6 years of Current Deferred Tax Assets data on file, last reported at $801.0 million in Q2 2016.

• Quarterly Current Deferred Tax Assets fell 40.75% year-over-year to $801.0 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $801.0 million (down 40.75% YoY) and the FY2015 annual result came in at $735.0 million, down 25.98% from the prior year.
• Current Deferred Tax Assets held at $801.0 million in Q2 2016, from $805.0 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $1.4 billion in Q2 2015 to a low of $735.0 million in Q4 2015.
• A 5-year average of $1.0 billion and a median of $1.0 billion in 2013 frame the typical range for Current Deferred Tax Assets.
• Annual changes were most pronounced in 2015 — Current Deferred Tax Assets grew 26.83% — and 2016, when it slumped 40.75%.
• Tracing TEVA's Current Deferred Tax Assets over 5 years: stood at $1.1 billion in 2012, then retreated by 5.08% to $1.1 billion in 2013, then dropped by 8.39% to $993.0 million in 2014, then dropped by 25.98% to $735.0 million in 2015, then climbed by 8.98% to $801.0 million in 2016.
• The last three Current Deferred Tax Assets figures came in at $801.0 million (Q2 2016), $805.0 million (Q1 2016), and $735.0 million (Q4 2015), per Business Quant data.